Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith T Zemanick

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Plos One|December 15, 2010
Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimensEdith T Zemanick, Brandie D Wagner, Scott D Sagel, et al.
Pediatric Pulmonology|May 27, 2010
Pulmonary exacerbations in cystic fibrosis with negative bacterial culturesEdith T Zemanick, Brandie D Wagner, J Kirk Harris, et al.
The Analyst|April 29, 2020
Nanodiagnostics to monitor biofilm oxygen metabolism for antibiotic susceptibility testingMegan P Jewell, Samuel C Saccomano, Alexa A David, et al.
Health Science Reports|February 22, 2021
Change in circulating proteins during treatment of pulmonary exacerbation in patients with cystic fibrosisBrandie D Wagner, Asem Berkalieva, Monica Borges, et al.
Pediatric Pulmonology|December 11, 2019
Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosisStacey L Martiniano, Charles R Esther, Charles S Haworth, et al.
Plos One|January 26, 2016
Molecular Identification of Staphylococcus aureus in Airway Samples from Children with Cystic FibrosisEmily J Johnson, Edith T Zemanick, Frank J Accurso, et al.
Pediatric Pulmonology|July 12, 2017
Highlights from the 2016 North American Cystic Fibrosis ConferenceEdith T Zemanick, Cori L Daines, Elisabeth P Dellon, et al.
Pediatric Pulmonology|November 14, 2025
Home Cough Monitoring Reveals Higher Nighttime Cough Burden in Children With Cystic Fibrosis Compared With Healthy ChildrenLilah D Melzer, Tim Vigers, Elinor T Hanley, et al.
Scientific Reports|January 21, 2023
Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosisAndrea Hahn, Aszia Burrell, Hollis Chaney, et al.
Diabetes Care|May 15, 2025
Trends in Cystic Fibrosis-Related Diabetes Epidemiology Between 2003 and 2018 From the U.S. Cystic Fibrosis Foundation Patient RegistryCelia L Kohler, Tim Vigers, Laura Pyle, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Plos One|December 15, 2010
Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimensEdith T Zemanick, Brandie D Wagner, Scott D Sagel, et al.
Pediatric Pulmonology|May 27, 2010
Pulmonary exacerbations in cystic fibrosis with negative bacterial culturesEdith T Zemanick, Brandie D Wagner, J Kirk Harris, et al.
The Analyst|April 29, 2020
Nanodiagnostics to monitor biofilm oxygen metabolism for antibiotic susceptibility testingMegan P Jewell, Samuel C Saccomano, Alexa A David, et al.
Health Science Reports|February 22, 2021
Change in circulating proteins during treatment of pulmonary exacerbation in patients with cystic fibrosisBrandie D Wagner, Asem Berkalieva, Monica Borges, et al.
Pediatric Pulmonology|December 11, 2019
Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosisStacey L Martiniano, Charles R Esther, Charles S Haworth, et al.
Plos One|January 26, 2016
Molecular Identification of Staphylococcus aureus in Airway Samples from Children with Cystic FibrosisEmily J Johnson, Edith T Zemanick, Frank J Accurso, et al.
Pediatric Pulmonology|July 12, 2017
Highlights from the 2016 North American Cystic Fibrosis ConferenceEdith T Zemanick, Cori L Daines, Elisabeth P Dellon, et al.
Pediatric Pulmonology|November 14, 2025
Home Cough Monitoring Reveals Higher Nighttime Cough Burden in Children With Cystic Fibrosis Compared With Healthy ChildrenLilah D Melzer, Tim Vigers, Elinor T Hanley, et al.
Scientific Reports|January 21, 2023
Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosisAndrea Hahn, Aszia Burrell, Hollis Chaney, et al.
Diabetes Care|May 15, 2025
Trends in Cystic Fibrosis-Related Diabetes Epidemiology Between 2003 and 2018 From the U.S. Cystic Fibrosis Foundation Patient RegistryCelia L Kohler, Tim Vigers, Laura Pyle, et al.
Pageof 9